CELLINO
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications. However, current autologous processes are not scalable due to extensive manual handling, high variability, and expensive facility overhead. Cellino’s vision is to make personalized regenerative medicines viable at large scale for the first time.
CELLINO
Industry:
Biotechnology Nanotechnology Product Design
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cellinobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
97.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Domain Not Resolving Apache Wordpress Plugins Sitelinks Search Box Euro
Similar Organizations
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Lux Labs
Lux Labs develops advanced optical materials using cutting edge nanophotonics and polymer fabrication methods.
Nelumbo
Nelumbo is Providing radical, lasting technological improvements to the heating and cooling industry.
Nomic Bio
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology.
OptoGlo
OptoGlo is a product development company that pioneer in the use of nanotechnology to produce transparent ultra-high-definition displays.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series A - Cellino
Humboldt Fund
Humboldt Fund investment in Series A - Cellino
8VC
8VC investment in Series A - Cellino
Felicis Ventures
Felicis Ventures investment in Series A - Cellino
Khosla Ventures
Khosla Ventures investment in Series A - Cellino
The Engine
The Engine investment in Series A - Cellino
The Engine
The Engine investment in Seed Round - Cellino
Khosla Ventures
Khosla Ventures investment in Seed Round - Cellino
Humboldt Fund
Humboldt Fund investment in Seed Round - Cellino
8VC
8VC investment in Seed Round - Cellino
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-27 | Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer |
Official Site Inspections
http://www.cellinobio.com Semrush global rank: 3.92 M Semrush visits lastest month: 3.23 K
- Host name: 28.149.62.50.host.secureserver.net
- IP address: 50.62.149.28
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Cellino"
Cellino Biotech
Our multidisciplinary team strives to make regenerative therapies accessible to all patients in need. We value unity, bravery, and kindness. Our diverse team works together, aligning individual efforts with our business priorities to drive Cellino …See details»
Cellino - Crunchbase Company Profile & Funding
Contact Email [email protected] Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized …See details»
Cellino - LinkedIn
BLOC is a 501(c)(3) non-profit organization dedicated to advancing representation and leadership for people of color in the biopharmaceutical and life sciences industries.See details»
Cellino Company Profile 2024: Valuation, Funding
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240052321-A1: Systems and methods for cell manufacturing: Pending: 15-Aug-2022See details»
Leaps by Bayer leads $80M Series A Financing for …
Jan 25, 2022 Cellino is an autonomous, closed loop cell therapy manufacturing company. The company is on a mission to democratize stem cell-based therapies for all eligible patients. Cellino is based in Cambridge, MA. For additional …See details»
Cellino Biotech
Cellino aims to significantly expand patient access to stem cell-based therapies with autonomous end-to-end manufacturing Proceeds will expand machine learning, software, and hardware capabilities and to develop early-stage Good …See details»
Cellino Biotech - Craft
Cellino Biotech is a biotechnology company that specializes in personalized regenerative medicine. Its platform combines label-free imaging and laser editing with machine learning to …See details»
Cellino Biotech | STEX - Startup
May 3, 2019 Saklayen started Cellino in 2017 with her former lab partner from Harvard University, physicist and nanomaterials expert, Marinna Madrid. Looking to build out their team on the engineering side, Saklayen and Madrid turned to …See details»
Cellino Biotech - Forbes
Dec 7, 2023 Cellino Biotech on the 2019 30 Under 30 - Healthcare - Stan Wang, a physician-scientist, and two physicists, Nabiha Saklayen and Marinna Madrid, teamedSee details»
Cellino Biotech, Inc. - BIO CEO & Investor Conference | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.cellinobio.com. Company …See details»
Bayer leads $80M funding round for Cellino, betting on new cell …
Jan 25, 2022 Cellino is guided by CEO Nabiha Saklayen, Ph.D., who helped create the company as she was studying for her doctorate at Harvard. In 2019, Saklayen and co-founders Marinna …See details»
Cellino Biotech - Work in biotech
Cellino Biotech is making personalized cell therapies for regenerative medicine. Stem cell derived-medicines have the possibility to treat several diseases from heart disease, diabetes to …See details»
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech …
Jan 25, 2022 Follow us on Twitter @cellinobio. Forward-Looking Statements. This release may contain forward-looking statements based on current assumptions and forecasts made by …See details»
Cellino is using AI and machine learning to scale production of …
Sep 22, 2021 Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, …See details»
Cellino Biotech
There are 7.8 billion humans on the planet today. No matter where we call home, every one of us contains the same building blocks, cells. Ten trillion cells in the human body work in …See details»
Cellino: Automating complex production, differentiation of iPS …
Jan 26, 2022 Cellino is aiming to bring iPS cell-derived cell therapies to the masses through an automated manufacturing process that can commercially scale the reprogramming of stem …See details»
Biotech Cellino Raising $75 Million for Stem Cell Therapies
Oct 26, 2021 Cellino is raising between $75 million and $80 million for a Series A round, sources told Insider. The startup is using artificial intelligence and lasers to develop treatments using …See details»
Cellino Biotech
The company has developed a scalable platform that automates and standardizes autologous stem cell production, accelerating the development of life-saving medicines for patients. …See details»
Cellino Biotech
Cell therapies offer the promise of reversing and even curing the most debilitating diseases, including diabetes and Parkinson’s. The long-awaited moment has arrived, and this week we …See details»